Rockland Trust CO Amgen Inc Transaction History

Rockland Trust CO

  • $1.95 Billion
  • Q4 2024

A detailed history of Rockland Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Rockland Trust CO holds 2,799 shares of AMGN stock, worth $808,547. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,799
Previous 2,928 4.41%
Holding current value
$808,547
Previous $943,000 22.69%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025
SELL
$258.78 - $328.31 $33,382 - $42,351
-129 Reduced 4.41%
2,799 $729,000
Q3 2024

Oct 03, 2024
SELL
$309.38 - $337.38 $42,694 - $46,558
-138 Reduced 4.5%
2,928 $943,000
Q2 2024

Jul 23, 2024
BUY
$262.75 - $319.31 $5,517 - $6,705
21 Added 0.69%
3,066 $957,000
Q1 2024

Apr 11, 2024
BUY
$268.87 - $324.56 $17,207 - $20,771
64 Added 2.15%
3,045 $865,000
Q4 2023

Jan 11, 2024
SELL
$255.7 - $288.46 $8,693 - $9,807
-34 Reduced 1.13%
2,981 $858,000
Q3 2023

Oct 26, 2023
SELL
$218.65 - $271.46 $19,459 - $24,159
-89 Reduced 2.87%
3,015 $810,000
Q2 2023

Jul 27, 2023
BUY
$214.27 - $253.37 $4,285 - $5,067
20 Added 0.65%
3,104 $689,000
Q1 2023

Apr 24, 2023
SELL
$225.79 - $275.2 $122,603 - $149,433
-543 Reduced 14.97%
3,084 $745,000
Q4 2022

Jan 24, 2023
SELL
$229.03 - $291.01 $53,134 - $67,514
-232 Reduced 6.01%
3,627 $952,000
Q3 2022

Oct 19, 2022
SELL
$224.46 - $253.15 $65,766 - $74,172
-293 Reduced 7.06%
3,859 $870,000
Q2 2022

Jul 13, 2022
SELL
$230.71 - $256.74 $61,599 - $68,549
-267 Reduced 6.04%
4,152 $1.01 Million
Q1 2022

Apr 18, 2022
SELL
$219.27 - $242.57 $76,963 - $85,142
-351 Reduced 7.36%
4,419 $1.07 Million
Q4 2021

Jan 27, 2022
BUY
$198.88 - $227.6 $78,557 - $89,902
395 Added 9.03%
4,770 $1.07 Million
Q3 2021

Oct 25, 2021
BUY
$212.27 - $248.7 $110,168 - $129,075
519 Added 13.46%
4,375 $930,000
Q2 2021

Jul 21, 2021
SELL
$233.58 - $259.14 $249,697 - $277,020
-1,069 Reduced 21.71%
3,856 $940,000
Q1 2021

Apr 22, 2021
SELL
$221.91 - $258.6 $73,230 - $85,338
-330 Reduced 6.28%
4,925 $1.23 Million
Q4 2020

Jan 04, 2021
BUY
$216.38 - $257.67 $58,855 - $70,086
272 Added 5.46%
5,255 $1.21 Million
Q3 2020

Oct 08, 2020
BUY
$234.65 - $260.95 $79,546 - $88,462
339 Added 7.3%
4,983 $1.27 Million
Q2 2020

Jul 09, 2020
SELL
$197.81 - $242.74 $50,837 - $62,384
-257 Reduced 5.24%
4,644 $1.1 Million
Q1 2020

Apr 16, 2020
SELL
$182.24 - $241.7 $511,000 - $677,726
-2,804 Reduced 36.39%
4,901 $995,000
Q4 2019

Jan 06, 2020
BUY
$189.21 - $243.2 $84,955 - $109,196
449 Added 6.19%
7,705 $1.86 Million
Q3 2019

Oct 11, 2019
BUY
$174.11 - $208.62 $479,324 - $574,330
2,753 Added 61.14%
7,256 $1.4 Million
Q2 2019

Jul 05, 2019
BUY
$166.7 - $195.41 $29,172 - $34,196
175 Added 4.04%
4,503 $830,000
Q1 2019

Apr 08, 2019
BUY
$180.87 - $203.88 $28,215 - $31,805
156 Added 3.74%
4,328 $823,000
Q4 2018

Jan 16, 2019
SELL
$178.4 - $208.25 $2,319 - $2,707
-13 Reduced 0.31%
4,172 $812,000
Q3 2018

Oct 05, 2018
BUY
$185.29 - $208.89 $50,213 - $56,609
271 Added 6.92%
4,185 $868,000
Q2 2018

Jul 06, 2018
SELL
$166.05 - $186.51 $85,515 - $96,052
-515 Reduced 11.63%
3,914 $722,000
Q1 2018

Apr 10, 2018
BUY
$169.43 - $198.0 $278,373 - $325,314
1,643 Added 58.97%
4,429 $755,000
Q4 2017

Jan 11, 2018
BUY
$168.79 - $188.59 $266,013 - $297,217
1,576 Added 130.25%
2,786 $484,000
Q3 2017

Nov 01, 2017
BUY
$167.29 - $191.0 $202,420 - $231,110
1,210
1,210 $226,000

Others Institutions Holding AMGN

# of Institutions
3,083
Shares Held
401M
Call Options Held
7.57M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rockland Trust CO Portfolio

Follow Rockland Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email